- Molecular NameEdrophonium
- SynonymEDR; Edrophone Chloride; Edrophonium Chloride; Edrophonium Ion; Edrophonum
- Weight166.244
- Drugbank_IDDB01010
- ACS_NO116-38-1
- Show 3D model
- LogP (experiment)N/A
- LogP (predicted, AB/LogP v2.0)-2.3
- pkaN/A
- LogD (pH=7, predicted)-2.34
- Solubility (experiment)N/A
- LogS (predicted, ACD/Labs)(ph=7)0.22
- LogSw (predicted, AB/LogsW2.0)256.44
- Sw (mg/ml) (predicted, ACD/Labs)276.55
- No.of HBond Donors1
- No.of HBond Acceptors2
- No.of Rotatable Bonds2
- TPSA20.23
- StatusFDA approved
- AdministrationIntramuscular
- PharmacologyA readily reversible acetylcholinesterase inhibitor. It prevents breakdown of the neurotransmitter acetylcholine and acts by competitively inhibiting the enzyme acetylcholinesterase, mainly at the neuromuscular junction.
- Absorption_value0.0
- Absorption (description)Rapidly absorbed.
- Caco_2N/A
- Bioavailability0.0
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmN/A
- Half life0.5 h
- ExcretionN/A
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityThe estimated minimum lethal dose is 100 mg.
- LD50 (rat)N/A
- LD50 (mouse)N/A